ClinicalTrials.gov
ClinicalTrials.gov Menu

Registry of Pediatric Patients Diagnosed With Crohn's Disease in Belgium (Belcro)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01241058
Recruitment Status : Completed
First Posted : November 16, 2010
Last Update Posted : January 20, 2016
Sponsor:
Information provided by (Responsible Party):
Gigi Veereman, Belgian Society for Pediatric Gastroentrology Hepatology and Nutrition

Brief Summary:
A registry of pediatric patients (under 18 yrs of age) diagnosed with Crohn's disease was created in Belgium. Over a 2 year period 257 patients are included. These patients will be follow up prospectively during 5 years. Demographic data, family history, disease presentation and disease course including medication are registered in CRF's.

Condition or disease
Description of Disease Course, Disease Fenotype, Medication, Safety, Analysis for Possible Associations

Study Type : Observational
Actual Enrollment : 257 participants
Observational Model: Cohort
Time Perspective: Prospective
Official Title: Belgian Registry of Pediatric Crohn's Disease
Study Start Date : May 2008
Actual Primary Completion Date : April 2015
Actual Study Completion Date : April 2015

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Crohn's Disease
U.S. FDA Resources




Primary Outcome Measures :
  1. disease course [ Time Frame: 5 years ]
    describe patient characteristics, disease fenotype and course



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   1 Year to 18 Years   (Child, Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
subjects under 18 yrs of age diagnosed with Crohn's disease, living in Belgium
Criteria

Inclusion Criteria:

1-18 yrs old belgian Crohn s disease informed consent

Exclusion Criteria:

no informed consent


Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01241058


Locations
Belgium
Bespghan
Leuven, Brabant, Belgium, 3000
Sponsors and Collaborators
Gigi Veereman

Publications of Results:

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Responsible Party: Gigi Veereman, MD PHD Pediatric Gastroenterologist, Belgian Society for Pediatric Gastroentrology Hepatology and Nutrition
ClinicalTrials.gov Identifier: NCT01241058     History of Changes
Other Study ID Numbers: Bespghan
First Posted: November 16, 2010    Key Record Dates
Last Update Posted: January 20, 2016
Last Verified: January 2016

Keywords provided by Gigi Veereman, Belgian Society for Pediatric Gastroentrology Hepatology and Nutrition:
pediatrics, crohn's disease, disease course, therapy

Additional relevant MeSH terms:
Crohn Disease
Disease Progression
Inflammatory Bowel Diseases
Gastroenteritis
Gastrointestinal Diseases
Digestive System Diseases
Intestinal Diseases
Disease Attributes
Pathologic Processes